| Breakdown | TTM | Sep 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.10M | 32.63M | 39.49M | 33.95M | 34.00M | 28.71M |
| Gross Profit | 9.45M | 12.75M | 14.49M | 11.24M | 11.95M | 12.17M |
| EBITDA | -3.85M | -2.60M | 1.14M | 307.00K | 362.00K | 3.16M |
| Net Income | 5.86M | 6.70M | -1.27M | -1.40M | 29.64M | 792.00K |
Balance Sheet | ||||||
| Total Assets | 52.83M | 54.24M | 55.20M | 60.51M | 60.45M | 26.48M |
| Cash, Cash Equivalents and Short-Term Investments | 3.67M | 7.40M | 4.12M | 9.73M | 15.27M | 4.46M |
| Total Debt | 4.16M | 5.84M | 3.87M | 1.47M | 1.22M | 4.42M |
| Total Liabilities | 12.56M | 15.00M | 14.76M | 18.74M | 16.97M | 10.75M |
| Stockholders Equity | 40.27M | 39.24M | 40.45M | 41.77M | 43.48M | 15.73M |
Cash Flow | ||||||
| Free Cash Flow | -9.87M | -5.79M | -3.42M | -2.97M | -239.00K | 2.71M |
| Operating Cash Flow | -9.81M | -5.74M | -2.63M | -1.79M | 1.11M | 2.90M |
| Investing Cash Flow | 8.90M | 7.58M | -5.47M | -3.54M | 15.96M | -2.23M |
| Financing Cash Flow | 1.87M | 1.44M | 2.49M | -206.00K | -6.25M | 1.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £8.16M | -9.72 | 12.70% | 2.64% | 6.86% | 64.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | £3.24M | ― | 66.17% | 26.13% | ― | ― | |
60 Neutral | £32.75M | 13.98 | 3.68% | 7.96% | -9.55% | ― | |
58 Neutral | £122.50M | 3.75 | 4.98% | ― | 15.42% | ― | |
56 Neutral | £14.77M | -2.99 | 14.74% | 2.12% | -17.37% | ― |